PlainRecalls
ModerateClass IITerminated

FDA Drug recall · Reported July 15, 2015

Losartan potassium tablets USP, 25 mg, 90- count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India NDC 60505-3160-9

Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.

Recall #
D-1212-2015
Affected scope
45,708 bottles
Initiated
May 29, 2015
Verify with FDA Drug →
View my saved recalls

Apotex Inc. recalled Losartan potassium tablets USP, 25 mg, 90- count bottle, Rx only, Manufactured for Apotex… - a moderate-severity action.

Losartan potassium tablets USP, 25 mg, 90- count bottle, Rx only, Manufactured for Apotex… was recalled by Apotex Inc. in July 15, 2015. Reason: Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specificati…. Check the official notice for the remedy. Verify recall #D-1212-2015 with the FDA Drug before acting.

The recall

Apotex Inc. issued this moderate-severity FDA Drug recall-Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specificati….

Moderate
severity level
Class II
classification
July 15, 2015
reported

Sourced from official FDA Drug enforcement records. Verify recall #D-1212-2015 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.

Recall Insight

This recall's affected scope, documented in the Recall Profile below, stays within a single-region or limited-distribution footprint. Distribution scope (see Distribution below) directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.

Within the same product category the archive holds 6 closely related recalls, 1 from FDA Drug - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.

Children & Baby Products recalls over time

Where this recall sits in its category - 3,781 children & baby products recalls on record

0100200300400500600 20052008201120142017202020232026 196
Severity1906864652High severity (most serious)Moderate severityLow severity
Where this agency-classified recall sits among FDA Class I/II/III notices

Of 88,244 recalls with an agency hazard classification, 19,068 are high severity, 64,652 moderate, and 4,524 low. A further 16,179 CPSC/NHTSA recalls have no agency class and are excluded from this split. This recall is classified moderate severity.

Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.

Product description

Losartan potassium tablets USP, 25 mg, 90- count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India NDC 60505-3160-9

Reason for recall

Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.

Recall Profile

Structured summary of the FDA Drug recall record
Attribute Value
Agency U.S. Food and Drug Administration
Severity class Moderate (Class II)
Status Terminated
Recall number D-1212-2015
Date reported July 15, 2015
Date initiated May 29, 2015
Recalling firm Apotex Inc.
Firm location Toronto, N/A
Affected scope 45,708 bottles
Distribution Nationwide, Hawaii and Puerto Rico

Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.

What to do with this recall

Match your product against the recall record, then act on the agency remedy.

  • Check the recall number (D-1212-2015) and product description against the item you own. Search the archive
  • Confirm the current status with FDA Drug before acting, recall details can be updated.
  • Follow the documented remedy (refund, replacement, repair, or disposal) rather than general advice. What to do next

This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.

Frequently Asked Questions

What product was recalled?
Losartan potassium tablets USP, 25 mg, 90- count bottle, Rx only, Manufactured for Apotex Inc 150 Signet Drive, ON M9L1T9 by Apotex Research Private Limited, Plot 1 & 2, Bommasandra Industrial Area, 4th Phase Jigani Link Road, Bangalore, Karnataka, 560099, India NDC 60505-3160-9. Recalled by Apotex Inc.. Units affected: 45,708 bottles.
Why was this product recalled?
Failed Content Uniformity Specifications: The product may not meet the limit for blend uniformity specification.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 15, 2015. Severity: Moderate. Recall number: D-1212-2015.
Where was the recalled product distributed?
Distribution: Nationwide, Hawaii and Puerto Rico.
Should I stop using a recalled medication or medical device?
Do not stop using a recalled medication or device without consulting your healthcare provider first, as abruptly discontinuing treatment could pose its own health risks. Your doctor can advise on alternatives or whether the recall applies to your specific product lot. Check the recall number and lot information against your product packaging.

Nationwide recalls with similar severity or category timing

Drug and device notices outside this firm and state, matched by severity timing and product category.

Compare this recall with CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per … → · All Children & Baby Products recalls

This recall: FDA Drug, reported July 15, 2015. Severity classes follow each agency's own taxonomy; related-recall context is computed across the full archive.

Methodology · Corrections · Archive as of August 2026